Keyphrases
Antibody-drug Conjugate
20%
Binding Specificity
20%
Biopsy Specimen
20%
Breast Cancer
20%
Breast Cancer Patients
80%
Clinical Trials
20%
Computational Imaging
20%
Dynamic PET
20%
Epithelial Tumor
20%
Folate Receptor
100%
Folate Receptor Expression
40%
HeLa
40%
Image-guided Intervention
100%
Immuno-positron Emission Tomography
20%
Immunohistochemical Evaluation
20%
ImmunoPET
100%
Immunoreactivity
20%
In Vitro Study
20%
Lung Cancer
20%
Maytansinoid
20%
Mirvetuximab Soravtansine
100%
Monoclonal Antibody
20%
Mouse Xenograft Model
20%
Non-invasive Device
20%
Ovarian Cancer
20%
OVCAR-3
20%
Paclitaxel
20%
Patient Screening
20%
Patient-centered
20%
Patient-derived Xenograft
40%
Pemetrexed
40%
PET Imaging
20%
PET-computed Tomography
20%
Radiotracer
20%
Receptor Binding
20%
Target Specificity
20%
Targeted Treatment
20%
Tissue Collection
20%
Treatment Efficacy
20%
Treatment Response
20%
Triple-negative Breast Cancer
100%
Tumor Biomarkers
20%
Tumor Heterogeneity
20%
Tumor Specimens
20%
Tumor Treatment
20%
Tumor Uptake
20%
Xenograft
20%
Zirconium-89 (89Zr)
100%
Medicine and Dentistry
Antibody-Drug Conjugate
14%
Biopsy Technique
14%
Breast Cancer
14%
Clinical Trial
14%
Computer Assisted Tomography
14%
Epithelioma
14%
Folate Receptor
100%
Image-Guided Intervention
100%
Immunoglobulin
100%
Immunoreactivity
14%
In Vitro
14%
Lung Cancer
14%
Mirvetuximab
100%
Mirvetuximab Soravtansine
100%
Neoplasm
28%
Ovarian Cancer
14%
Paclitaxel
14%
Pemetrexed
28%
Polyethylene Terephthalate
100%
Positron Emission Tomography
42%
Radioactive Tracer
14%
Receptor Binding
14%
Receptor Expression
28%
Sensitivity and Specificity
14%
Targeted Therapy
14%
Tissue Banking
14%
Treatment Response
14%
Triple Negative Breast Cancer
100%
Tumor Marker
14%
Tumour Heterogeneity
14%
Xenograft
57%
Zirconium 89
85%